Estiva 600 Capsule






Active Ingredient (Generic Name)  

Bictegravir 50 mg, Emtricitabine 200 mg, Tenofovir Alafenamide 25 mg
Indication HIV
Manufacturer Hetero Healthcare
Packaging 30 Tablets in a Pack
Delivery Time 6 to 15 Days
Trust Badge Image


TAFFIC is a three-drug fixed-dose combination medication that contains 50 mg bictegravir (BIC), 200 mg emtricitabine (FTC), and 25 mg tenofovir alafenamide (TAF). One tablet of TAFFIC should be taken once a day, with or without meals. TAFFIC is indicated for the treatment of HIV-1 infection in adults who have never received antiretroviral therapy or to replace an existing antiretroviral regimen in those who are virologically suppressed (HIV-1 RNA less than 50 copies per mL) and have been on a stable antiretroviral regimen for at least 3 months with no history of treatment failure and no known substitutions associated with resistance to Bictegravir, Emtricitabine, or Tenofovir


There are no reviews yet.

Be the first to review “TAFFIC”

Your email address will not be published.